Australia’s leading research commercialisation company
UniQuest manages the intellectual property of The University of Queensland.
News
UQ research into developing new treatments for conditions such as cancer, inflammatory diseases and type 1 diabetes has received recognition and funding support from a national incubator for biomedical startup companies.
Working in partnership with University of Queensland researchers, UQ commercialisation company UniQuest has secured $3 million in funding for the four startups under the first round of the Medical Research Future Fund (MRFF)’s national $40 million CUREator Scheme.
Events
Industry Connect
Industry Connect events enable pre-qualified collaborations between industry and researchers.
Workshop
We host free, two-day Research Commercialisation Workshops for UQ’s early-career researchers.
Impact Stories
From idea to impact, UniQuest commercialises UQ research to create change.

Gardasil®: A global solution to eradicating cervical cancer
From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to an approximate 90 per cent decrease in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

Better gut health with the world's first encapsulated probiotic drink
The world’s first encapsulated probiotic drink uses patented technology to deliver beneficial bacteria safely to the gut. PERKii® is sold in more than 2000 stores across Australia and New Zealand.

Bringing the benefits of positive parenting to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world, thanks to the work of leading researchers at UQ and the acumen of licensee Triple P International Pty Ltd.
Available technologies
Our specialised team delivers the highest quality commercialisation expertise and can help you access the world class research, resources and intellectual property of The University of Queensland. We have a suite of available technologies and discoveries for licensing or investment.